0
NPS
Learn More about Brand Intelligence Solutions
Find out what hundreds of thousands of customers are saying about your brand, your competitors and others in the industry
Thank you for inquiring about Comparably's Brand Intelligence Solutions
A member from Comparably's team member will be reaching out shortly to set up a time to speak about our Brand Intelligence Solutions
Brand Page
Esperion Therapeutics
Marketing or Exec? Claim Your Free Account
About Esperion Therapeutics' Brand
Esperion is a pharmaceutical company that specializes in developing and commercializing oral therapies for the treatment of patients with elevated LDL-C. Among its major competitors, Esperion Therapeutics is ranked in 2nd place for NPS while Biogen is 1st, and Neurocrine Biosciences is 3rd.Their current market cap is $129.76M
Brand at a Glance
69%
Customer Loyalty
3.3/5
Product Quality
2.7/5
Pricing
3.1/5
Customer Service
Esperion Therapeutics Ranking
- #2 / 4 of its competitors
Esperion Therapeutics NPS
Esperion Therapeutics's Net Promoter Score (NPS) is a 0 with 45% Promoters, 10% Passives, and 45% Detractors. Net Promoter Score tracks whether Esperion Therapeutics's customers would recommend using the product based on a scale of -100 to 100.
Esperion Therapeutics Overall NPS
| 45% | Promoters |
|---|---|
| 10% | Passives |
| 45% | Detractors |
Esperion Therapeutics NPS Trend
-100
-50
0
50
100
| Summary | Date | Score |
|---|---|---|
Apr 2020 50 | Apr 2020 | 50 |
Sep 2020 0 | Sep 2020 | 0 |
Oct 2020 25 | Oct 2020 | 25 |
Oct 2021 0 | Oct 2021 | 0 |
Nov 2021 -29 | Nov 2021 | -29 |
Dec 2021 -13 | Dec 2021 | -13 |
May 2022 0 | May 2022 | 0 |
May 2023 -10 | May 2023 | -10 |
Mar 2025 0 | Mar 2025 | 0 |
How Other Brands Compare
Esperion Therapeutics is ranked second for NPS among its competitors. Biogen and Neurocrine Biosciences come in first and third, with MyoKardia coming in at #4. Among those competitors, it is the lowest valued company behind Biogen.
Esperion Therapeutics |  Biogen |  MyoKardia | Neurocrine Biosciences | |
| Global Ranking | #- | #388 | #- | #- |
| NPS | 0 | 21 | - | -50 |
| Social Sentiment Calculated by analyzing social media and other online mentions | - | Neutral | Neutral | - |
| Valuation Updated every 24 hours for public companies | $129.76M | $42.46B | $11.99B | $9.11B |
What is NPS
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Esperion Therapeutics NPS vs. Competitors
Compared to its competitors, Esperion Therapeutics's NPS is rated right above MyoKardia, and is preceded by Biogen.
| COMPANY | NPS Score | |
|---|---|---|
| Biogen | 21 |
| Esperion Therapeutics | 0 |
| MyoKardia | N/A |
 | Reata Pharmaceuticals | N/A |
| Neurocrine Biosciences | -50 |
Esperion Therapeutics Customer Loyalty
69%
Customer Loyalty is a strong indicator of whether or not a customer will choose a brand repeatedly over a competitor that offers similar products/services.
69% of Esperion Therapeutics users/customers answered "Yes" when asked: "Would you consider yourself a loyal user/customer?"
Sign Up to see the full customer demographics data and the people that answered "Yes" when asked "Would you consider yourself a loyal user/customer?"
Esperion Therapeutics Customer Loyalty vs. Competitors
Compared to its competitors, Esperion Therapeutics's Customer Loyalty score is rated right above Reata Pharmaceuticals, and is preceded by Biogen.
| COMPANY | Customer Loyalty Score | |
|---|---|---|
| Neurocrine Biosciences | 100% |
| MyoKardia | 100% |
| Biogen | 75% |
| Esperion Therapeutics | 69% |
| Reata Pharmaceuticals | N/A |
Unlock Esperion Therapeutics Customer Loyalty vs. Competitors Data
VS
Sign Up for Brand Profile PRO to get the full Esperion Therapeutics Customer Loyalty vs. Competitors data and gain insights into your customers today.
Esperion Therapeutics Product Quality
3.3/5
Esperion Therapeutics has an overall Product Quality score of 3.3 out of 5 stars rated by its users and customers.
Sign Up to unlock Esperion Therapeutics' overall Product Quality score rated by its users and customers.
Esperion Therapeutics Product Information
Esperion Therapeutics’s product quality score is a 3.3 out of 5 as rated by its users and customers.
- Website
- http://www.esperion.com
- Company Size
- 51-200 Employees
Industry
Biotech and Pharmaceuticals
Esperion Therapeutics Product Quality vs. Competitors
Compared to its competitors, Esperion Therapeutics's Product Quality score is rated right above Reata Pharmaceuticals, and is preceded by MyoKardia.
| COMPANY | Product Quality Score | |
|---|---|---|
| Neurocrine Biosciences | 5/5 |
| Biogen | 4/5 |
| MyoKardia | 4/5 |
| Esperion Therapeutics | 3.3/5 |
| Reata Pharmaceuticals | N/A |
Unlock Esperion Therapeutics Product Quality vs. Competitors Data
VS
Sign Up for Brand Profile PRO to get the full Esperion Therapeutics Product Quality vs. Competitors data and gain insights into your customers today.
Esperion Therapeutics Pricing
Esperion Therapeutics ROI & Value For Money
2.7/5
Esperion Therapeutics has a value for money and ROI score of 2.7 out of 5 stars rated by its users and customers.
Sign Up to unlock Esperion Therapeutics' overall ROI score rated by its users and customers.
Esperion Therapeutics Pricing vs. Competitors
Compared to its competitors, Esperion Therapeutics's ROI score is rated right above Neurocrine Biosciences, and is preceded by Biogen.
| COMPANY | Pricing Score | |
|---|---|---|
| MyoKardia | 4/5 |
| Biogen | 3.8/5 |
| Esperion Therapeutics | 2.7/5 |
| Neurocrine Biosciences | 1.5/5 |
| Reata Pharmaceuticals | N/A |
Unlock Esperion Therapeutics ROI vs. Competitors Data
VS
Sign Up for Brand Profile PRO to get the full Esperion Therapeutics ROI vs. Competitors data and gain insights into your customers today.
Esperion Therapeutics Customer Satisfaction (CSAT)
Esperion Therapeutics Customer Satisfaction (CSAT) Score
60 / 100
Esperion Therapeutics has an overall Customer Satisfaction score of 60 rated by its users and customers.
Sign Up to see the full customer demographics data and the people that answered "How would you rate your overall satisfaction with the service you received?"
Very Satisfied
20%
Satisfied
40%
Neither Satisfied nor Dissatisfied
0%
Dissatisfied
0%
Very Dissatisfied
40%
What is Customer Satisfaction (CSAT) Score
Customer Satisfaction Score (also known as CSAT), is a metric used to quantify how satisfied customers are with a company or brand’s products and services. The Customer Satisfaction Score is based on customers response to the question: “How would you rate your overall satisfaction with the service you received?” The score is calculated using the formula: (The total number answer of “Very Satisfied” and “Satisfied”) ÷ (The total response) x100, and it is generally displayed in percentages. Some of the main benefits of the CSAT for businesses are tracking retention, identifying happy customers and growing relationships, and gaining repeat business to build a sustainable brand.
Esperion Therapeutics Customer Satisfaction vs. Competitors
Compared to its competitors, Esperion Therapeutics's Customer Satisfaction score is rated right above MyoKardia, and is preceded by Biogen.
| COMPANY | Customer Satisfaction (CSAT) Score | |
|---|---|---|
| Neurocrine Biosciences | 100% |
| Biogen | 78% |
| Esperion Therapeutics | 60% |
| MyoKardia | 0% |
| Reata Pharmaceuticals | 0% |
Unlock Esperion Therapeutics Customer Satisfaction vs. Competitors Data
VS
Sign Up for Brand Profile PRO to get the full Esperion Therapeutics Customer Satisfaction vs. Competitors data and gain insights into your customers today.
Esperion Therapeutics Customer Service
3.1/5
Esperion Therapeutics has an overall Customer Service score of 3.1 out of 5 stars rated by its users and customers.
Sign Up to unlock Esperion Therapeutics' overall Customer Service score rated by its users and customers.
About Esperion Therapeutics's Customer Service
Address
3891 Ranchero Drive, Suite 150, Ann Arbor, MI 48108
Website
http://www.esperion.com
Phone Number
734-887-3903
Esperion Therapeutics's Social Links
Esperion Therapeutics Customer Service vs. Competitors
Compared to its competitors, Esperion Therapeutics's Customer Service score is rated right above Neurocrine Biosciences, and is preceded by Biogen.
| COMPANY | Customer Service Score | |
|---|---|---|
| MyoKardia | 4/5 |
| Biogen | 3.8/5 |
| Esperion Therapeutics | 3.1/5 |
| Neurocrine Biosciences | 1.5/5 |
| Reata Pharmaceuticals | N/A |
Unlock Esperion Therapeutics Customer Service vs. Competitors Data
VS
Sign Up for Brand Profile PRO to get the full Esperion Therapeutics Customer Service vs. Competitors data and gain insights into your customers today.
Esperion Therapeutics as an Employer
2.3/5
Esperion Therapeutics has a 2.3/5 stars for its overall company culture rated by their employees
bottom
5%
CEO of Esperion Therapeutics
In the Bottom 5% of Similar Sized Companies on Comparably.
Consumer vs. Employees
Esperion Therapeutics scored a 0 for Net Promoter Score and a -87 for Employee Net Promoter Score. NPS gauges how likely a customer of Esperion Therapeutics would recommend the brand to a friend. ENPS measures how likely Esperion Therapeutics employees would recommend working at Esperion Therapeutics to a friend.
Net Promoter Score
0
NPS Score
| 45% | Promoters |
|---|---|
| 10% | Passive |
| 45% | Detractors |
Employee Net Promoter Score
-87
eNPS Score
| 0% | Promoters |
|---|---|
| 13% | Passive |
| 87% | Detractors |
